1.

Record Nr.

UNINA9910453419503321

Titolo

Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy [[electronic resource]]

Pubbl/distr/stampa

Lyon, France, : International Agency for Research on Cancer

Geneva, : Distributed by WHO Press, 2007

ISBN

1-281-82961-7

9786611829612

92-4-068321-6

Descrizione fisica

1 online resource (543 p.)

Collana

IARC monographs on the evaluation of carcinogenic risks to humans ; ; v. 91

Soggetti

Progestational hormones - Carcinogenicity

Progestational hormones - Side effects

Catechol estrogens - Carcinogenicity

Estrogen - Carcinogenicity

Catechol estrogens - Side effects

Estrogen - Side effects

Contraception - Complications

Menopause - Hormone therapy - Complications

Chemical carcinogenesis

Cancer - Risk factors

Women - Diseases - Risk factors

Oral contraceptives - Carcinogenicity

Electronic books.

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

At head of title: World Health Organization, International Agency for Research on Cancer.

"This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 7-14 June 2005."

Nota di bibliografia

Includes bibliographical references and cumulative index.

Nota di contenuto

Preliminaries; CONTENTS; PREAMBLE; Combined Estrogen-Progestogen Contraceptives; Combined Estrogen-Progestogen Menopausal Therapy;



ANNEXES; CUMULATIVE INDEX TO THE MONOGRAPHS SERIES;

Sommario/riassunto

Oral contraceptives for family planning worldwide have revolutionized the reproductive lives of millions of women since their introduction in the 1960's. Later on, a variety of side-effects including cardiovascular diseases was recognized. In response to these concerns, new generations of combined oral contraceptives were developed that featured lower dose of estrogen and newer, more potent progestogens. The effectiveness and ease of use of combined hormonal contraceptives suggest that they will continue to be used to a significant extent in the future. This ninety-first volume of IARC Monographs